PinkDx is a Biotech company based in Daly City, California. It has raised $40M in total funding. Latest round: Series A.
PinkDx funding overview
PinkDx is a Biotech company based in Daly City, California. PinkDx has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2024. The round record for PinkDx runs through 2024; nothing later has been disclosed. Investors on record include Catalio Capital Management, LP, The Production Board, Mountain Group Partners, Byers Capital, Mayo Clinic. 5 distinct backers are named across the disclosed rounds.
PinkDx at a glance
Total raised
$40M
Latest round
Series A
Latest round date
April 2024
Industry
Biotech
Headquarters
Daly City, California
Notable investors
Catalio Capital Management, LP, The Production Board, Mountain Group Partners, Byers Capital, Mayo Clinic
Frequently asked about PinkDx funding
How much has PinkDx raised?
PinkDx has raised $40M in total disclosed funding across the rounds on record.
Who has invested in PinkDx?
Catalio Capital Management, LP, The Production Board, Mountain Group Partners, Byers Capital, Mayo Clinic are named among the investors backing PinkDx.
What was the latest PinkDx funding round?
The most recent disclosed round is a Series A, announced in April 2024.
Where is PinkDx based?
PinkDx is based in Daly City, California.
What sector does PinkDx operate in?
PinkDx is tracked under Biotech from Daly City, California, with $40M in disclosed funding.
When did PinkDx last raise?
The last disclosed PinkDx round closed in April 2024 at Series A.
Round data for PinkDx is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Daly City and backer lists below.
